Abstract
The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered Report describes the proposed replication plan of key experiments from "Melanoma genome sequencing reveals frequent PREX2 mutations" by Berger and colleagues, published in Nature in 2012 (Berger et al., 2012). The key experiments that will be replicated are those reported in Figure 3B and Supplementary Figure S6. In these experiments, Berger and colleagues show that somatic PREX2 mutations identified through whole-genome sequencing of human melanoma can contribute to enhanced lethality of tumor xenografts in nude mice (Figure 3B, S6B, and S6C; Berger et al., 2012). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.
Keywords
Reproducibility Project: Cancer Biology
cancer genomics
cell biology
driver mutations
human biology
medicine
melanoma
methodology
mouse
MeSH Terms
Genome, Human/genetics
Guanine Nucleotide Exchange Factors/genetics
Humans
Melanoma/genetics
Mutation/genetics
Sunlight/adverse effects
Chemicals
Guanine Nucleotide Exchange Factors
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Chroscinski Denise
Noble Life Sciences, Gaithersburg, United States.
Sampey Darryl
BioFactura, Frederick, United States.
Hewitt Alex
Department of Clinical Genetics, University of Melbourne, Melbourne, Australia.
Reproducibility Project: Cancer Biology
References (13)
13 references, click to expand
-
Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation.
J Chronic Dis. 1981;34(9-10):469-79
PMID: 7276137
-
Sample-size formula for the proportional-hazards regression model.
Biometrics. 1983 Jun;39(2):499-503
PMID: 6354290
-
Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a.
Science. 2009 Sep 4;325(5945):1261-5
PMID: 19729658
-
Whole genome sequencing of matched primary and metastatic acral melanomas.
Genome Res. 2012 Feb;22(2):196-207
PMID: 22183965
-
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Cancer Discov. 2012 May;2(5):401-4
PMID: 22588877
-
Melanoma genome sequencing reveals frequent PREX2 mutations.
Nature. 2012 May 24;485(7399):502-6
PMID: 22622578
-
A landscape of driver mutations in melanoma.
Cell. 2012 Jul 20;150(2):251-63
PMID: 22817889
-
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
Nat Genet. 2012 Sep;44(9):1006-14
PMID: 22842228
-
Mutational heterogeneity in cancer and the search for new cancer-associated genes.
Nature. 2013 Jul 11;499(7457):214-8
PMID: 23770567
-
Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma.
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3640-9
PMID: 24003131
-
Oncogenes in melanoma: an update.
Eur J Cell Biol. 2014 Jan-Feb;93(1-2):1-10
PMID: 24468268
-
A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.
Mol Cancer Ther. 2014 Jul;13(7):1918-28
PMID: 24755198
-
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
Neuro Oncol. 2014 Nov;16(11):1499-509
PMID: 24968695